SHARMA EAST INDIA HOSPITALS & MEDICAL RESEARCH LTD.

Sharma East India Hospitals & Medical Research Ltd has announced its 37th Annual General Meeting (AGM) will be held on September 30, 2026, at 3:00 PM IST. The meeting will be conducted via Video Conferencing or Other Audio-Visual means, in compliance with MCA and SEBI regulations. Key agenda items include the adoption of the Audited Financial Statements for the financial year ended March 31, 2026, and the re-appointment of Radhika Sathe as a Director. Additionally, the members will consider a special business item regarding the determination of a fee for document delivery. The notice and annual report are available on the company's website.

Sharma East India Hospitals & Medical Research Ltd announced the outcome of its Board Meeting held on September 08, 2026. The board approved the Director's Report and Annual Report for the Financial Year ended March 31, 2026. They also approved the convening of the 37th Annual General Meeting (AGM) on September 30, 2026, with e-voting commencing on September 27, 2026. The Register of Members and Share Transfer Books will be closed from September 24 to September 30, 2026, for the AGM.

Sharma East India Hospitals & Medical Research Ltd announced the approval of its unaudited standalone financial results for the quarter ended June 30, 2026. The company's Board of Directors met to review and approve these results, along with the limited review report from its auditors, Gopal Sharma & Co. The filing confirms adherence to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Indian Accounting Standard 34.

Sharma East India Hospitals & Medical Research Ltd announced the approval of its un-audited standalone financial results for the quarter ended June 30, 2026. The Board of Directors approved these results along with the Limited Review Report during their meeting held on August 12, 2026. The financial statements are compliant with IND-AS and prepared in accordance with Indian Accounting Standard 34. The results are available on the company's website.

Sharma East India Hospitals & Medical Research Ltd has announced that its Board of Directors will convene on August 12, 2026. The primary agenda item is to consider and approve the IND-AS compliant Standalone Un-audited Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report. The meeting will also address any other business as permitted. The company has also reminded stakeholders that the trading window for securities remains closed until 48 hours after the declaration of these financial results, in accordance with its Insider Trading Code.

Sharma East India Hospitals & Medical Research Ltd has announced the closure of its trading window for designated persons. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the announcement of the standalone unaudited financial results for the quarter ended June 30, 2026. The purpose of this closure is to facilitate the consideration of these financial results.

Sharma East India Hospitals & Medical Research Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the Standalone Audited Financial Results along with the Auditor's Report for the year ended March 31, 2026, pursuant to regulation 33 of SEBI (LODR) Regulation, 2015. The trading window for dealing in the company's securities has been closed from April 1, 2026, until 48 hours after the declaration of the financial results.

Sharma East India Hospitals & Medical Research Ltd. has announced the closure of its trading window for all designated persons. This closure is effective from Wednesday, April 1, 2026, and is in preparation for the consideration of the company's Standalone Audited Financial Results for the quarter and year ended March 31, 2026. The trading window will reopen 48 hours after the announcement of the financial results becomes generally available.

Sharma East India Hospitals & Medical Research Ltd announced the approval of its unaudited financial results for the quarter ended December 31, 2025. The company's revenue from operations for the quarter was Rs. 960.88 lakhs, representing a growth of approximately 17% compared to the same period last year. The total revenue for the quarter stood at Rs. 965.38 lakhs, while the total expenses amounted to Rs. 940.51 lakhs. As a result, the company reported a profit before tax of Rs. 24.87 lakhs and a net profit of Rs. 17.77 lakhs for the quarter. The earnings per share (EPS) for the quarter stood at Rs. 0.54.

Sharma East India Hospitals & Medical Research Ltd. announced the approval of their standalone un-audited financial results for the quarter ended December 31, 2025, in compliance with Regulation 33 of the Listing Obligation and Disclosure Requirement, 2015. The meeting was held on February 14, 2026, and the board approved the IND-AS compliant Standalone un-audited Financial Results. The company's revenue from operations for the quarter is Rs. 960.88 lakhs, with a profit before tax of Rs. 24.87 lakhs and a profit for the period of Rs. 17.77 lakhs.